Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.50 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5563786 | 1.00 | TDP1 (0.50) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL23111329 | 0.93 | TDP1 (0.57) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL18302412 | 0.93 | TDP1 (0.57) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL5556273 | 0.89 | SMN1; SMN2 (0.61) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL5556275 | 0.89 | SMN1; SMN2 (0.61) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL7523864 | 0.86 | TDP1 (0.47) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL7523860 | 0.86 | TDP1 (0.47) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL13960891 | 0.84 | TDP1 (0.52) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL6864944 | 0.84 | SMN1; SMN2 (0.52) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL6864956 | 0.84 | SMN1; SMN2 (0.52) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140350256-A1 | IRON AND MANGANESE COMPLEXES COMPRISING HEXADENTATE MONOCARBOXYLATO-CONTAINING LIGANDS AND THEIR USE FOR THE CATALYSIS OF OXIDATION REACTIONS | UNIVERSITY OF SOUTHERN DENMARK (DK) | 2014-11-27 | — | — | US | disclosed |
| EP-1341893-B1 | ENZYMATIC DETERGENT COMPOSITIONS | UNILEVER NV (NL) | 2007-05-02 | — | — | EP | disclosed |
| EP-1109965-B1 | METHOD OF TREATING A TEXTILE | UNILEVER PLC (GB) | 2005-06-01 | — | — | EP | disclosed |
| EP-1008645-B1 | Detergent bleaching compositions | UNILEVER PLC (GB) | 2004-07-21 | — | — | EP | disclosed |
| EP-1433840-A1 | Composition and method for bleaching a substrate | UNILEVER PLC (GB) | 2004-06-30 | — | — | EP | disclosed |
| EP-1001009-B1 | Bleach and oxidation catalyst | UNILEVER PLC (GB) | 2003-09-03 | — | — | EP | disclosed |
| US-20030050211-A1 | Enzymatic detergent compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-03-13 | — | — | US | disclosed |
| US-20020137654-A1 | Enzymatic detergent compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-09-26 | — | — | US | disclosed |
| US-20020066542-A1 | Transition metal complexes with polydentate ligands for enhancing the bleaching and delignifying effect of peroxo compounds | DEGUSSA AG (DE) | 2002-06-06 | — | — | US | disclosed |
| EP-1129170-A1 | BLEACH AND OXIDATION CATALYST | UNILEVER PLC (GB) | 2001-09-05 | — | — | EP | disclosed |
| US-6245115-B1 | N,N-BIS(PYRIDIN-2-YL-METHYL)-1,1-BIS(PYRIDIN-2-YL)-1-AMINOETHA NE COMPLEX WITH ACETONITRILE AND PERCHLORIC ACID, WHEREBY THE COMPLEX CATALYSES BLEACHING OF THE TEXTILE BY ATMOSPHERIC OXYGEN | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2001-06-12 | — | — | US | disclosed |
| US-6242409-B1 | PERCHLORATE IRON COMPLEX OF ACETONITRILE AND N,N-BIS(PYRIDIN-2-YL-METHYL)-1,1-BIS(PYRIDIN-2-YL)-1-AMINOETHA NE, THE COMPLEX CATALYSING BLEACHING OF A SUBSTRATE BY THE ATMOSPHERIC OXYGEN; PEROXY BLEACH FREE. | UNILEVER HOME & PERSONAL CARE USA | 2001-06-05 | — | — | US | disclosed |
| US-6165963-A | Detergent bleaching composition comprising pentadentate ligand derivatives | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| US-6140294-A | OXIDATION CATALYST COMPRISING AN IRON, MANGANESE OR COPPER COMPLEX INCLUDING A SPECIFIED PENTADENTATE NITROGEN-CONTAINING LIGAND | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2000-10-31 | — | — | US | disclosed |
| EP-1008645-A1 | Detergent bleaching compositions | UNILEVER PLC (GB) | 2000-06-14 | — | — | EP | disclosed |
| WO-2000027976-A1 | BLEACH AND OXIDATION CATALYST | UNILEVER PLC (GB) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000027975-A1 | DETERGENT BLEACHING COMPOSITION | UNILEVER PLC (GB) | 2000-05-18 | — | — | WO | disclosed |
| EP-1001009-A1 | Bleach and oxidation catalyst | UNILEVER PLC (GB) | 2000-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350256-A1 | IRON AND MANGANESE COMPLEXES COMPRISING HEXADENTATE MONOCARBOXYLATO-CONTAINING LIGANDS AND THEIR USE FOR THE CATALYSIS OF OXIDATION REACTIONS | ME3, SOD3, SOD1 | TDP1 4330/4885MAPT 2997/4885SMN1; SMN2 3341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.